Metabolic and Genetic Screening of Electromagnetic Hypersensitive Subjects as a Feasible Tool for Diagnostics and Intervention

Figure 8

Selected representative omega-6 and omega-3 polyunsaturated fatty acids (PUFA) of erythrocytes membrane phospholipid fatty acids (FA), in the groups of patients self-reporting electromagnetic hypersensitivity (EHS, 𝑛=58), of patients affected by multiple chemical sensitivity without EHS symptoms (MCS, 𝑛=54), and of control healthy subjects (CTR, 𝑛=70). (a) % C18:2𝜔6; (b) C20:4𝜔6; (c) C18:3𝜔6; (d) C22:6𝜔3 FAs, on total FA content of phospholipids. Values are represented as mean (□), standard error of the mean (upper and lower limits of the box), and 1.96× standard error (upper and lower whiskers). Intergroup significant differences (P) are reported under each panel. RBC: red blood cells. 18:2𝜔6 (linoleic acid), 18:3𝜔6 (alpha linolenic acid), 20:4𝜔6 (arachidonic acid), and 22:6𝜔3 (docosahexaenoic acid).

(a)

(b)

(c)

(d)